NASDAQ:TRUPTrupanion Stock Price, Forecast & News

Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 102.8% and is now trading at $52.82.
View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Trupanion.

Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020.
View our earnings forecast for Trupanion.

Trupanion Inc (NASDAQ:TRUP) released its quarterly earnings results on Thursday, April, 30th. The financial services provider reported ($0.03) EPS for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.01. The financial services provider earned $111.30 million during the quarter, compared to the consensus estimate of $110.10 million. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. Trupanion's revenue for the quarter was up 28.0% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.04) earnings per share.
View Trupanion's earnings history.

8 Wall Street analysts have issued 1-year target prices for Trupanion's stock. Their forecasts range from $20.00 to $50.00. On average, they expect Trupanion's stock price to reach $39.29 in the next twelve months. This suggests that the stock has a possible downside of 25.6%.
View analysts' price targets for Trupanion.

Media stories about TRUP stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trupanion earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned news coverage about the financial services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Trupanion.

Trupanion saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 7,360,000 shares, a decline of 8.2% from the June 30th total of 8,020,000 shares. Based on an average daily volume of 370,900 shares, the short-interest ratio is currently 19.8 days. Approximately 25.6% of the shares of the stock are short sold.
View Trupanion's Current Options Chain.

Some companies that are related to Trupanion include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Advanzeon Solutions (CHCR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), McEwen Mining (MUX), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Baidu (BIDU), Gilead Sciences (GILD), Starbucks (SBUX) and Splunk (SPLK).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Trupanion's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Thomas Story & Son LLC (0.25%), Frontier Capital Management Co. LLC (0.25%), First Trust Advisors LP (0.16%), SG Americas Securities LLC (0.05%), Hamilton Lane Advisors LLC (0.04%) and Parallel Advisors LLC (0.04%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

TRUP stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Thomas Story & Son LLC, First Trust Advisors LP, Banque Cantonale Vaudoise, and Dupont Capital Management Corp. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Margaret Tooth, Murray B Low, and Tricia Plouf.
View insider buying and selling activity for Trupanion.

TRUP stock was bought by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Hamilton Lane Advisors LLC, Parallel Advisors LLC, SG Americas Securities LLC, Leap Investments LP, Sciencast Management LP, Arizona State Retirement System, and Lyell Wealth Management LP.
View insider buying and selling activity for Trupanion.

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TRUP stock can currently be purchased for approximately $52.82.

Trupanion has a market capitalization of $1.85 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]